Novavax, Inc. announced a private placement to issue 6,500,000 common shares at an issue price of $13 per share for the gross proceeds of $84,500,000 on August 8, 2023. The transaction will include participation from new investor SK bioscience Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59,800 KRW | -0.17% | +1.70% | -16.94% |
May. 03 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
Mar. 28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
59,800 KRW | -0.17% | +1.70% | 3.36B | ||
12.9 USD | +45.27% | +181.09% | 1.25B | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.94% | 3.36B | |
-2.35% | 89.08B | |
+2.76% | 40.9B | |
-13.39% | 32.25B | |
+54.69% | 25.14B | |
-16.43% | 15.39B | |
-8.90% | 11.91B | |
-42.60% | 11.89B | |
-12.82% | 11.64B | |
+7.34% | 9.03B |
- Stock Market
- Equities
- A302440 Stock
- News SK bioscience Co.,Ltd.
- Novavax, Inc. announced that it expects to receive $84.5 million in funding from SK bioscience Co.,Ltd.